New Insights into the Pathophysiology of the Small Airways in Asthma - 20/08/11
Résumé |
Airway inflammation and remodeling in asthma occur in the central airways and also in the small airways and in the lung parenchyma. The small airways and the lung parenchyma can produce many Th2 cytokines, chemokines, and mediators involved in initiation and perpetuation of the inflammatory process. The distal lung has been recognized as a predominant site of airflow obstruction in asthmatics. Distal inflammation has been described as more severe than large airway inflammation, and strong evidence of remodeling in the lung periphery is emerging. Recognition of asthma as a disease of the entire respiratory tract has clinical significance, highlighting the need to target the distal lung in any strategy for effective treatment of this disease.
Le texte complet de cet article est disponible en PDF.Plan
| This work was supported in part by the Canadian Institutes of Health Research Canada, GlaxoSmithKline, the Canadian Lung Association, and 3M Pharmaceuticals. Dr. Tulic is a National Health and Medical Research Council Peter Doherty Post-Doctoral Fellow, and Dr. Hamid is a recipient of the Senior FRSQ Chercheur-Boursier Award. |
Vol 27 - N° 1
P. 41-52 - mars 2006 Retour au numéro
Article précédent
- Physiologic and Pathologic Abnormalities in Severe Asthma
- Sally Wenzel
- Airway Smooth Muscle as a Regulator of Immune Responses and Bronchomotor Tone
- Aili L. Lazaar, Reynold A. Panettieri
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?